Tofacitinib 5 mg twice daily ( DrugBank: Tofacitinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
84サルコイドーシス1

84. サルコイドーシス


臨床試験数 : 149 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03910543
(ClinicalTrials.gov)
April 11, 20194/4/2019Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareOpen-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareCutaneous Sarcoidosis;Granuloma AnnulareDrug: Tofacitinib 5 mg twice dailyYale UniversityPfizerCompleted18 YearsN/AAll15Phase 1United States